{
    "2021-08-25": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Lilly Announces that Professor Carolyn Bertozzi has Resigned from its Board of Directors",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Professor Carolyn Bertozzi",
                        "Resigned",
                        "Board of Directors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Lycia Therapeutics",
                        "Strategic Collaboration",
                        "Discover",
                        "Develop",
                        "LYTAC Degraders"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "3 Big Drug/Biotech Outperformers Worth Keeping an Eye On (Revised)",
                "features": {
                    "keywords": [
                        "Drug",
                        "Biotech",
                        "Outperformers",
                        "Worth Keeping an Eye On"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}